source
- Europe’s share of clinical trials falls 13.5% as Asia’s research footprint expandsThe latest data show a 13.5% drop in the number of clinical trials authorized in the EU and EEA compared with pre-pandemic levels. At the same time, Asian countries have increased their share of g…
- Parkinson’s-focused Aspen and bispecific biotech Bambusa plan IPOsParkinson’s disease cell therapy-focused Aspen Neuroscience and bispecific biotech Bambusa Therapeutics are the latest drug developers to eye up a public listing.Fierce Biotech · 10d ago↗ source
- Novartis licenses Abogen’s mRNA CD19×CD3 engager in $575M upfront deal